Triple-marker prenatal screening program for chromosomal defects

Obstetrics and Gynecology

Volumn 114, Issue 1, 2009, Pages 50-58

  Kazerouni, N Neely ^a   Cunier, Bob ^a   Malm, Linda ^a   Riggle, Susan ^a   Hodgkinson, Christina ^a   Smith, Sylvia ^a   Tempelis, Corinna ^a   Lorey, Fred ^a   Davis, Amber ^a   Jelliffe Pawlowski, Laura ^a   Walton Haynes, Lynn ^a   Roberson, Marie ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; AMNIOCENTESIS; ANALYTICAL EQUIPMENT; ARTICLE; BIRTH CERTIFICATE; BIRTH DEFECT; CHROMOSOME ABERRATION; CYTOGENETICS; DELIVERY; DOWN SYNDROME; FEMALE; FETUS; FETUS ECHOGRAPHY; FOLLOW UP; GENETIC COUNSELING; HEALTH PROGRAM; HUMAN; KLINEFELTER SYNDROME; LABORATORY TEST; LIVE BIRTH; MAJOR CLINICAL STUDY; MANDATORY REPORTING; MATERNAL AGE; PREGNANCY; PREGNANCY TERMINATION; PRENATAL CARE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; REGISTER; SPONTANEOUS ABORTION; TRIPLOIDY; TRISOMY 13; TRISOMY 18; TURNER SYNDROME; UNITED STATES;

ADOLESCENT; ADULT; AMNIOCENTESIS; CHILD; CHROMOSOME DISORDERS; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; MATERNAL AGE; MIDDLE AGED; NAIL-PATELLA SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; TRISOMY; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 67651046799     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181a9479e     Document Type: Article

References (20)

1. Cunningham GC, Tompkinison DG. Cost and effectiveness of the California triple marker prenatal screening program. Genet Med 1999;1:199-206.
2. California Code of Regulations, Title 17, Section 6532. Current as of January 09, 2009. Available at: http://ccr.oal.ca.gov/ linkedslice/default.asp? SP=CCR-1000&Action=Welcome. Retrieved January 09, 2009.
3. Wald NJ, Cuckle HS, DensemJW, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down's syndrome in early pregnancy [published erratum appears in BMJ 1988;297:1029]. BMJ 1988;297:883-7.
4. Palomaki GE, Haddow JE, Knight GJ, Wald NJ, Kennard A, Canick JA, et al. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn 1995;15:713-23.
5. Morris JK, Mutton DE, Alberman E. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen 2002;9:2-6.
6. Morris JK, Wald NJ, Watt HC. Fetal loss in Down syndrome pregnancies. Prenat Diagn 1999;19:142-5.
7. Palomaki GE, Bradley LA, McDowell GA, Down syndrome working group, ACMG Laboratory Quality Assurance Committee. Technical standards and guidelines: prenatal screening for Down syndrome. Genet Med 2005;7:344-54.
8. SAS Institute, Inc. SAS software of statistical analysis. Version 9.1.3. Cary (NC): SAS Institute, Inc.; 2005.
9. National Center for Health Statistics. 2006 birth tables. National Vital Statistics System. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics. Available at: http://205.207.175.93/ VitalStats/TableViewer/tableView.aspx?ReportId=15095.
10. ACOG educational bulletin. Maternal serum screening. Number 228, September 1996 (replaces no. 154, April 1991). Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1996;55:299-308.
11. Wald NJ, Kennard A, Hackshaw A, McGuire A. Antenatal screening for Down's syndrome [published erratum appears in J Med Screen 1998;5:110.J Med Screen 1998;5:166]. J Med Screen 1997;4:181-246.
12. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 2003; 10:56-104.
13. Bray IC, Wright DE. Estimating the spontaneous loss of Down syndrome fetuses between the times of chorionic villus sampling, amniocentesis and livebirth. Prenat Diagn 1998;18: 1045-54.
14. Cuckle H. Down syndrome fetal loss rate in early pregnancy. Prenat Diagn 1999;19:1177-9.
15. Halliday JL, Watson LF, Lumley J, Danks DM, Sheffield LJ. New estimates of Down syndrome risks at chorionic villus sampling, amniocentesis, and livebirth in women of advanced maternal age from a uniquely defined population. Prenat Diagn 1995;15:455-65.
16. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353: 2001-11.
17. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, et al. First-trimester screening for trisomies 21 and 18. N EnglJ Med 2003;349:1405-13.
18. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005;25:221-6.
19. Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA. First- and second trimester screening: detection of aneuploidies other than Down syndrome. Obstet Gynecol 2007;110:651-7.
20. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217-27.